financetom
Business
financetom
/
Business
/
Update: PayPal Shares Fall as Q1 Non-GAAP Earnings Guidance Suggests Sequential Decline
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: PayPal Shares Fall as Q1 Non-GAAP Earnings Guidance Suggests Sequential Decline
Feb 4, 2025 9:55 AM

12:30 PM EST, 02/04/2025 (MT Newswires) -- (Updates with the latest stock movement in the headline and first paragraph.)

PayPal Holdings ( PYPL ) shares dropped nearly 11% in recent Tuesday trading after the company issued Q1 non-GAAP earnings guidance that suggests a sequential decline from Q4.

The company earlier reported Q4 non-GAAP earnings of $1.19 per diluted share, up from $1.14 a year earlier.

Analysts polled by FactSet expected $1.12.

Net revenue for the quarter ended Dec. 31 was $8.37 billion, compared with $8.03 billion a year earlier.

Analysts polled by FactSet expected $8.26 billion.

The company said it expects Q1 non-GAAP EPS of $1.15 to $1.17. Analysts polled by FactSet expect $1.13.

PayPal ( PYPL ) said it expects 2025 non-GAAP EPS of $4.95 to $5.10. Analysts polled by FactSet expect $4.90.

The company also said its board approved a new $15 billion share buyback program in addition to its 2022 repurchase authorization, which had remaining balance of $4.86 billion as of Dec. 31.

Price: 79.86, Change: -9.66, Percent Change: -10.79

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Portage Reports 'Promising' Preclinical Results in Mesothelioma
Portage Reports 'Promising' Preclinical Results in Mesothelioma
Mar 27, 2025
05:11 PM EDT, 03/27/2025 (MT Newswires) -- Portage Biotech ( PRTG ) reported late Thursday encouraging efficacy data in a murine mesothelioma model with PORT-7 given as a single agent or in combination with anti-PD-1 antibody. The data showed both single agent activity, and more than 90% inhibition of tumor growth when PORT-7 was combined with an anti-PD1 antibody in...
Lumen Technologies Refinances Debt, Extends Maturity
Lumen Technologies Refinances Debt, Extends Maturity
Mar 27, 2025
05:16 PM EDT, 03/27/2025 (MT Newswires) -- Lumen Technologies ( LUMN ) late Thursday said its subsidiary, Level 3 Financing, has refinanced its existing term loans with a new $2.4 billion term loan maturing in 2032. The new loan is priced at a term secured overnight financing rate plus 4.25% and extends the maturity of Level 3's debt by 30...
Elutia Enters GPO Deal With Advantus Health Partners
Elutia Enters GPO Deal With Advantus Health Partners
Mar 27, 2025
05:16 PM EDT, 03/27/2025 (MT Newswires) -- Elutia ( ELUT ) said Thursday it entered an agreement to offer EluPro to Advantus Health Partners' group purchasing organizations solutions portfolio . EluPro is an antibiotic-eluting bio envelope designed for use with neurostimulators and cardiac implantable electronic devices. The biomatrix regenerates into the patient's tissue to minimize post-operative challenges, the company said....
Bancorp Gets Nasdaq Notice Over Late Filing of Annual Report
Bancorp Gets Nasdaq Notice Over Late Filing of Annual Report
Mar 27, 2025
05:16 PM EDT, 03/27/2025 (MT Newswires) -- Bancorp (TBBK) received a noncompliance notice from Nasdaq after the company failed to file its annual report on Form 10-K for 2024 on time with the Securities and Exchange Commission. The notice has no immediate effect on the listing or share trading, the company said Thursday in a statement. The company has 60...
Copyright 2023-2026 - www.financetom.com All Rights Reserved